Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Lommatzsch

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|December 20, 2014
[Change of therapy from ranibizumab to aflibercept for recurrent or persistent exudative age-related macular degeneration]M Ziegler, B Heimes, B Book, et al.
Eye (London, England)|May 21, 2011
Sub-lytic C5b-9 induces functional changes in retinal pigment epithelial cells consistent with age-related macular degenerationK Lueck, S Wasmuth, J Williams, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|September 27, 2019
[Treatment adherence and effectiveness of anti-Vascular Endothelial Growth Faktor(VEGF) treatment of diabetic macular edema in the clinical routine : Comparison between cooperative and unicentric organization of treatment]H Faatz, K Rothaus, D Westhues, et al.
Klinische Monatsblatter Fur Augenheilkunde|June 25, 2013
[Current Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for therapeutic intravitreal application of Ocriplasmin (JETREA ®) in ophthalmology (May 2013)]K-U Bartz-Schmidt, B Bertram, N Bornfeld, et al.
Die Ophthalmologie|September 20, 2022
[Prospective noninterventional BLUE SKY study evaluating the efficacy of brolucizumab in treatment-naïve and previously treated patients with neovascular AMD]H Faatz, N Feltgen, M Gutfleisch, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|December 20, 2014
[Change of therapy from ranibizumab to aflibercept for recurrent or persistent exudative age-related macular degeneration]M Ziegler, B Heimes, B Book, et al.
Eye (London, England)|May 21, 2011
Sub-lytic C5b-9 induces functional changes in retinal pigment epithelial cells consistent with age-related macular degenerationK Lueck, S Wasmuth, J Williams, et al.
Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|September 27, 2019
[Treatment adherence and effectiveness of anti-Vascular Endothelial Growth Faktor(VEGF) treatment of diabetic macular edema in the clinical routine : Comparison between cooperative and unicentric organization of treatment]H Faatz, K Rothaus, D Westhues, et al.
Klinische Monatsblatter Fur Augenheilkunde|June 25, 2013
[Current Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for therapeutic intravitreal application of Ocriplasmin (JETREA ®) in ophthalmology (May 2013)]K-U Bartz-Schmidt, B Bertram, N Bornfeld, et al.
Die Ophthalmologie|September 20, 2022
[Prospective noninterventional BLUE SKY study evaluating the efficacy of brolucizumab in treatment-naïve and previously treated patients with neovascular AMD]H Faatz, N Feltgen, M Gutfleisch, et al.
Pageof 5